Is the risk the same for everyone?
No. The type of lymphoma matters.

Non-Hodgkin Lymphoma (NHL): The risk for this has dropped by over 70% since modern ART became the standard.

Hodgkin Lymphoma (HL): Surprisingly, the risk for this hasn't dropped as much and, in some studies, actually appears slightly more often in people with "healthier" immune systems on ART compared to those with very low CD4 counts.

What to Look For
Because these cancers can be aggressive, early detection is key. You should contact your doctor if you notice "B-Symptoms":

Painless swelling of lymph nodes (neck, armpit, or groin) that doesn't go away.

Drenching night sweats (enough to need to change your pajamas).

Unexplained weight loss (losing 10% of your body weight without trying).

Persistent fevers with no other signs of a cold or flu.

The Good News: In 2026, the success rate for treating lymphoma in people with HIV is almost the same as it is for the general population. Being on ART actually makes the cancer treatment more effective because it keeps your immune system strong enough to handle chemotherapy.

It is heavy news to process, but the short answer is yes, lymphoma can still develop even while someone is on antiretroviral therapy (ART). However, the risk is dramatically lower today than it was in the past.

Here is a breakdown of why this happens, the timing, and what to watch for.

Why does it still happen?
While ART is incredible at suppressing the virus in your blood, HIV-associated lymphoma is a complex issue. There are two main reasons it can still develop:

Immune Memory: If a person’s immune system was severely damaged (a very low CD4 count) before they started treatment, the "scars" on the immune system can sometimes lead to the development of cancer years later.

Inflammation: HIV can cause chronic "overstimulation" of the immune system. Even when the virus is undetectable in the blood, it can still hide in the lymph nodes, causing low-level inflammation that may eventually trigger a cell to become cancerous.

How long does it take?
There isn't a single "timer," but researchers have observed a few patterns in the timing:

The Early Phase (The First 6 Months): In some cases, lymphoma can appear shortly after starting ART. This is sometimes called IRIS (Immune Reconstitution Inflammatory Syndrome). As the immune system "wakes up," it may suddenly start attacking a small, pre-existing pocket of cancer cells that it was too weak to notice before.

The Long-Term Phase (Years Later): Most cases today occur in people who have been on treatment for many years. This is often linked to the natural process of aging combined with having lived with HIV for a long time.

The "Nadir" Factor: The risk is more about how low your CD4 count went before you started treatment (your "nadir") and how long it stayed there, rather than how long you have been on the meds themselves.